BioNTech veröffentlicht Ergebnisse für das erste Quartal 2024 sowie Informationen zur Geschäftsentwicklung
May 06, 2024 06:45 ET
|
BioNTech SE
BioNTech ist auf einem gutem Weg, das Jahresziel von zehn oder mehr potenziell zulassungsrelevanten Studien in der Pipeline bis Ende 2024 zu erreichen: weitere Phase-3-Studie mit der Behandlung der...
BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
May 06, 2024 06:45 ET
|
BioNTech SE
Advancing toward goal of ten or more potentially registrational trials running by the end of 2024: first patient dosed in Phase 3 clinical trial evaluating BNT323/DB-1303 in HR+ HER2-low...
Lilium Announces Firm Order of 20 Lilium Jets from U.S. Operator UrbanLink
May 06, 2024 06:30 ET
|
Lilium GmbH
UrbanLink’s firm purchase order of 20 Lilium Jets, with an option for 20 more, includes scheduled pre-delivery payments.The agreement marks a critical aviation milestone as UrbanLink becomes the first...
Hut 8 Operations Update for April 2024
May 06, 2024 06:30 ET
|
Hut 8 Corp.
26.6 EH/s and 1.2 GW under management Salt Creek site fully energized and Cedarvale site partially energized MIAMI, May 06, 2024 (GLOBE NEWSWIRE) -- Hut 8 Corp. (Nasdaq...
Freshpet, Inc. Reports First Quarter 2024 Financial Results
May 06, 2024 06:30 ET
|
Freshpet, Inc.
Company Updates 2024 Outlook; Raises Adjusted EBITDA GuidanceNet Sales Driven by Volume-Based Growth Profitability Improvement Driven by Lower Input, Quality and Logistics Costs SECAUCUS, N.J., May ...
Hut 8 Operations Update for April 2024
May 06, 2024 06:30 ET
|
Hut 8 Corp.
Miami, May 06, 2024 (GLOBE NEWSWIRE) -- Hut 8 Corp. (Nasdaq | TSX: HUT) (“Hut 8” or the “Company”), a leading, vertically integrated operator of large-scale energy infrastructure and one of North...
Oculis to Present at Bank of America Global Healthcare Conference
May 06, 2024 06:30 ET
|
Oculis Holding AG
ZUG, Switzerland, and BOSTON, USA, May 06, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”) a global biopharmaceutical company purposefully driven to...
Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider
May 06, 2024 06:25 ET
|
GENENTA SCIENCE SPA
MILAN, Italy and NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a clinical-stage immuno-oncology company developing a cell-based platform harnessing the power...
H World Group Limited Schedules First Quarter of 2024 Earnings Release on May 17, 2024
May 06, 2024 06:15 ET
|
H World Group Limited
SINGAPORE and SHANGHAI, China, May 06, 2024 (GLOBE NEWSWIRE) -- H World Group Limited (NASDAQ: HTHT and HKEX: 1179) (“H World”, “we” or “our”) a key player in the global hotel industry, today...
MannKind Receives U.S. FDA Fast Track Designation for Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease
May 06, 2024 06:05 ET
|
MannKind
MANNKIND RECEIVES U.S. FDA FAST TRACK DESIGNATION FOR CLOFAZIMINE INHALATION SUSPENSION FOR THE TREATMENT OF SERIOUS LUNG DISEASE